SCHEMBL22929960

SCHEMBL22929960

c1cc(-c2ccc3c(c2)-c2ccccc2-c2ccccc2-c2cc(-n4c5ccccc5c5ccccc54)ccc2-3)nc(-c2ccc3c(c2)-c2ccccc2-c2ccccc2-c2ncccc2-3)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 6/20 0.35
MCL1 Q07820 4/20 0.33
PTPRC P08575 2/20 0.32
CTSL P07711 1/20 0.32
CTSS P25774 1/20 0.32
PTPN13 Q12923 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPY5R Q15761 1/20 0.32
MAPK14 Q16539 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PPP1CA P62136 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PDK2 Q15119 1/20 0.32
AKT1 P31749 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22929959 0.91 PIM1 (0.32) TGFBR1MCL1PTPRCCTSLCTSS
SCHEMBL22929888 0.90 MAPT (0.38) MCL1PTPRCCTSLCTSSPTPN13
SCHEMBL22930027 0.88 KDM4E (0.41) MCL1PTPRCCTSLCTSSPTPN13
SCHEMBL22929956 0.86 MAPT (0.38) TGFBR1MCL1KDM4ECYP1A2MAPT
SCHEMBL22929955 0.86 ATM (0.35) TGFBR1PTPRCKDM4EATML3MBTL1
SCHEMBL22929893 0.85 PTPRC (0.31) PTPRCCTSLCTSSPTPN13KDM4E
SCHEMBL22929904 0.84 KDM4E (0.42) MCL1PTPRCCTSLCTSSPTPN13
SCHEMBL22930035 0.84 CYP11B2 (0.32) TGFBR1PTPRCCTSLCTSSPTPN13
SCHEMBL22929924 0.83 ALDH1A1 (0.34) PTPRCCTSLCTSSPTPN13ATM
SCHEMBL20062479 0.80 KDM4E (0.34) PTPRCKDM4EATML3MBTL1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910577-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910577-B2 Organic electroluminescent materials and devices CACNA2D2, ORC3, ANO2 TGFBR1 3552/4885MCL1 3151/4885PTPRC 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.